Filing Details

Accession Number:
0001181431-11-018228
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-15 18:59:10
Reporting Period:
2011-03-11
Filing Date:
2011-03-15
Accepted Time:
2011-03-15 18:59:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1183765 Threshold Pharmaceuticals Inc THLD Pharmaceutical Preparations (2834) 943409596
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1360787 G John Curd C/O Threshold Pharmaceuticals, Inc.
1300 Seaport Blvd. Suite 500
Redwood City CA 94063
President And Cmo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-03-11 11,904 $2.10 127,841 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants (Right to Buy) Acquisiton 2011-03-11 4,761 $2.10 4,761 $2.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,761 2011-03-16 2016-03-16 No 4 P Direct
Footnotes
  1. Acquired from Issuer pursuant to a Prospectus Supplement dated March 11, 2011.
  2. Includes 3,000 shares acquired under the Issuer's Employee Stock Purchase Plan on August 13, 2010, and 3,000 shares acquired under the Issuer's Employee Stock Purchase Plan on February 12, 2011 at a per share price of $1.003.
  3. Purchase price per unit. Each unit consists of 1 common share and a warrant to purchase 0.4 of a share of common stock at an exercise price of $2.46 per share.